Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperthyroidism and cardiovascular morbidity and mortality.

Faizel Osman1, Michael D Gammage, Jayne A Franklyn

  • 1Department of Cardiovascular Medicine, Queen Elizabeth Hospital, University of Birmingham, Edgbaston, Birmingham, England.

Thyroid : Official Journal of the American Thyroid Association
|August 8, 2002
PubMed
Summary

Even treated hyperthyroidism may lead to long-term cardiovascular risks. Studies show increased mortality from heart and brain diseases, even with subclinical hyperthyroidism, highlighting the need for ongoing monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAGNETOcardiography Parameters to Predict Sudden Cardiac Death (MAGNETO-SCD) or Ventricular Events From Implantable Cardioverter Defibrillators.

JACC. Clinical electrophysiology·2026
Same author

Sex-disaggregated data in hypertrophic cardiomyopathy: a targeted literature review, meta-analysis and primary cohort study.

Open heart·2026
Same author

Discovery of Novel Magnetocardiography Parameters Predicting Future ICD Therapies: Insights From the Magneto-SCD Study.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Use of Disopyramide in Obstructive Hypertrophic Cardiomyopathy: A European Insight.

Journal of clinical medicine·2026
Same author

From mapping to clipping: The role of thoracoscopic left atrial appendage clipping in refractory focal left atrial tachycardia.

HeartRhythm case reports·2026
Same author

Pace-and-ablate in a flash: Ablation of the atrioventricular node with pulsed field ablation.

HeartRhythm case reports·2025

Area of Science:

  • Endocrinology
  • Cardiology
  • Public Health

Background:

  • Hyperthyroidism, an overactive thyroid, impacts multiple body systems, notably the cardiovascular system.
  • Effective treatments foster a belief in hyperthyroidism's complete reversibility, overlooking potential long-term adverse outcomes.
  • Emerging evidence indicates persistent health risks even after hyperthyroidism treatment.

Purpose of the Study:

  • To investigate the long-term cardiovascular and cerebrovascular consequences of treated hyperthyroidism.
  • To assess the mortality risks associated with both overt and subclinical hyperthyroidism.
  • To explore the role of thyroid hormone effects on cardiac and vascular systems.

Main Methods:

  • Long-term follow-up studies were conducted on patients with a history of hyperthyroidism.

Related Experiment Videos

  • Analysis included mortality data from cardiovascular and cerebrovascular events.
  • The study considered patients treated with radioiodine and those with subclinical hyperthyroidism.

    • Main Results:

    • Increased mortality from cardiovascular and cerebrovascular diseases was observed in individuals with a history of overt hyperthyroidism treated with radioiodine.
    • Subclinical hyperthyroidism was also associated with elevated mortality risks.
    • Thyroid hormones directly affect the myocardium and vasculature, predisposing to arrhythmias like atrial fibrillation.

    Conclusions:

    • Hyperthyroidism, even when treated, may not be entirely reversible and can lead to lasting cardiovascular and cerebrovascular damage.
    • Atrial fibrillation, a known complication of hyperthyroidism, contributes to increased mortality through embolic phenomena.
    • Long-term monitoring is crucial for patients with a history of hyperthyroidism, including subclinical cases, to mitigate associated health risks.